Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate plus DOS neoadjuvant therapy for advanced gastric cancer
ChiCTR2400092985Phase 2Not yet recruiting
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of magnesium sulfate in gastric adenocarcinoma (2 arms), sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoint: Tumor regression grade. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
magnesium sulfate
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on ChiCTR2400092985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092985.